Clinical trial

Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children

NCT00364104 · The University of Texas Health Science Center, Houston, Other · Completed

Key facts

NCT number NCT00364104
Title Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
Official title Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas
Acronym HEIDC
Lead sponsor The University of Texas Health Science Center, Houston, Other
Collaborators Texas Tech University University of Texas Baylor College of Medicine University of North Texas Health Science Center
Status Completed
Phase Phase 3
Study type Interventional
Conditions Iron Deficiency
Intervention type Drug
Interventions Quadruple sequential Helicobacter pylori eradication + iron sulfate, Quadruple sequential Helicobacter pylori eradication therapy, Ferrous sulfate, Placebo
Enrollment 125
Start date Mar 1, 2007
Primary completion Dec 1, 2008
Completion Dec 1, 2008
First posted Aug 15, 2006
Last update posted Jun 30, 2009
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies